BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/20/2014 6:36:00 PM | Browse: 979 | Download: 1182
 |
Received |
|
2014-02-27 14:17 |
 |
Peer-Review Started |
|
2014-02-27 21:13 |
 |
To Make the First Decision |
|
2014-04-15 20:06 |
 |
Return for Revision |
|
2014-04-27 12:18 |
 |
Revised |
|
2014-05-12 03:25 |
 |
Second Decision |
|
2014-06-13 16:01 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2014-06-13 16:09 |
 |
Articles in Press |
|
2014-06-13 16:27 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2014-07-03 21:12 |
 |
Typeset the Manuscript |
|
2014-09-27 14:59 |
 |
Publish the Manuscript Online |
|
2014-10-20 18:35 |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Case Report |
Article Title |
Complete response to sorafenib in a patient with recurrent hepatocellular carcinoma
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Hong-Bo Huan, Wan-Yee Lau, Feng Xia, Kuan-Sheng Ma and Ping Bie |
Funding Agency and Grant Number |
|
Corresponding Author |
Feng Xia, MD, PhD, Institute of Hepatobiliary Surgery, Southwest Hospital, Southwest Cancer Center, Third Military Medical University, No. 30 Gaotanyan Street, Shapingba District, Chongqing 400038, China. txzzxf@163.com |
Key Words |
Hepatocellular carcinoma; Partial hepatectomy; Sorafenib; Complete response |
Core Tip |
For patients with multiple recurrent hepatocellular carcinoma (HCC) after partial hepatectomy which cannot be treated by re-hepatectomy or local ablative therapy, the prognosis is extremely poor. Our case showed that the patient with recurrent HCC treated with sorafenib can achieve a complete clinical response as it did in advanced HCC. |
Publish Date |
2014-10-20 18:35 |
Citation |
Huan HB, Lau WY, Xia F, Ma KS, Bie P. Complete response to sorafenib in a patient with recurrent hepatocellular carcinoma. World J Gastroenterol 2014; 20(39): 14505-14509 |
URL |
http://www.wjgnet.com/1007-9327/full/v20/i39/14505.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v20.i39.14505 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345